These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28115456)

  • 1. Higher medication doses in heart failure?
    McCormack J; McAlister FA; Kolber MR
    Can Fam Physician; 2017 Jan; 63(1):e20. PubMed ID: 28115456
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.
    Tavazzi L; Maggioni AP; Borer JS
    Eur Heart J; 2013 Sep; 34(36):2792-4. PubMed ID: 23892200
    [No Abstract]   [Full Text] [Related]  

  • 3. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, Ī²-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.
    Driscoll A; Currey J; Tonkin AM
    JAMA Cardiol; 2016 Oct; 1(7):842-843. PubMed ID: 27556747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith I; Jackson I
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
    Ahmed A
    J Am Coll Cardiol; 2003 May; 41(10):1851-2. PubMed ID: 12767683
    [No Abstract]   [Full Text] [Related]  

  • 6. Adherence to Treatment Guidelines in Heart Failure Patients in the Top End Region of Northern Territory.
    Mu M; Majoni SW; Iyngkaran P; Haste M; Kangaharan N
    Heart Lung Circ; 2019 Jul; 28(7):1042-1049. PubMed ID: 29980453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep; 144(35-36):57. PubMed ID: 12380364
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality.
    Shah T; Deswal A
    Ann Intern Med; 2016 Apr; 164(8):JC41. PubMed ID: 27089090
    [No Abstract]   [Full Text] [Related]  

  • 9. [New prospects in diagnosis and treatment of heart failure].
    Pfister U; Lerch R; Hess OM
    Praxis (Bern 1994); 2002 Jan; 91(5):177-80. PubMed ID: 11865776
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC
    Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure.
    Dilokthornsakul P; Chaiyakunapruk N; Nimpitakpong P; Jeanpeerapong N; Sruamsiri R
    Value Health; 2012; 15(1 Suppl):S9-14. PubMed ID: 22265074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
    Rogers FJ; Saghir Z
    J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of beta-blockaders in heart failure].
    Gullestad L; Kjekshus J
    Tidsskr Nor Laegeforen; 2003 Mar; 123(5):651-2. PubMed ID: 12683197
    [No Abstract]   [Full Text] [Related]  

  • 14. [Male-female differences in the optimal dosage of medication for heart failure; the 'one-size-fits-all' approach to guidelines needs revision].
    Groenewegen A; Mosterd A; Rutten FH
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: ResultsĀ From BIOSTAT-CHF.
    Ouwerkerk W; Zwinderman AH; Ng LL; Demissei B; Hillege HL; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Ter Maaten JM; Lang CC; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Voors AA
    J Am Coll Cardiol; 2018 Jan; 71(4):386-398. PubMed ID: 29389354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperkalemia, heart failure and reduced renal function].
    Bugge JF
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1354-5. PubMed ID: 20596118
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmocological therapeutics for chronic heart failure--how to use ARB (angiotensin receptor blocker].
    Kudo Y; Komuro I; Akazawa H
    Nihon Rinsho; 2007 May; 65 Suppl 5():84-9. PubMed ID: 17571370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)].
    Erdmann E
    MMW Fortschr Med; 2005 Sep; 147(39):11. PubMed ID: 16245770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Support in heart failure: major paradigm shift or small step?].
    Tafer N; Fumeaux T
    Rev Med Suisse; 2014 Oct; 10(447):2004. PubMed ID: 25518215
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].
    MMW Fortschr Med; 2002 Nov; 144(45):58. PubMed ID: 12534067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.